New Document top_band
 
Business Standard

Sun Pharma gains on acquisition of URL generic biz

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco.

Read more on:    Url | Takeda | Sun Pharma
Related News

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of pharma through its subsidiary for an undisclosed amount.

“Caraco Pharmaceutical Laboratories, wholly-owned subsidiary of the company, has entered into a definitive agreement with Pharmaceuticals U.S.A., Inc, a wholly-owned subsidiary of Takeda Pharmaceutical Company, to buy the URL Pharma, Inc. generic business,” said in a statement.

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, it added.

The stock opened at Rs 727 and hit a high of Rs 733 on the NSE. A combined 138,547 shares have changed hands on the counter in morning deals.

Read more on:   
|
|

Read More

Two entities fail to make prima facie case to revoke ban: Sebi

The Securities and Exchange Board of India (Sebi) today said the restraining order on two entities, related to plunge in some mid-cap stocks in July, ...

Quick Links

 

Market News

Crude palm oil up 0.2% on spot demand

Oil for delivery in July moved up marginally by 0.14%

Lead up 0.3% on spot demand

Metal for delivery in August gained 0.07%

Copper down 0.1% on global cues, weak demand

Metal for delivery in far-month November traded lower by 0.08%

Cardamom up 1% on spot demand

Traders enlarge commitments as tight stocks following lower arrivals from growing regions fuel uptrend

Nickel sheds 0.25% on subdued demand

Lower offtake from alloy makers drives prices down, but gains in London cap losses

Back to Top